The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
Sutter Health, OSF HealthCare, University Hospitals and others are entering expensive, long-term partnerships for key devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback